A 63-year-old with confirmed MRSA cellulitis and systemic signs is started on vancomycin. Which monitoring approach aligns with 2020 consensus?...

Question

A 63-year-old with confirmed MRSA cellulitis and systemic signs is started on vancomycin. Which monitoring approach aligns with 2020 consensus?

Accepted Answer

AUC-guided dosing/monitoring rather than trough-only

Answer

Fixed 1 g q12h without monitoring

Answer

Peak levels only

Answer

No monitoring is necessary

Answer

Rely on trough 15-20 mg/L exclusively for all cases

us-abim MCQ (SBA): Vancomycin Therapeutic Monitoring